Browsing by Author Tilley, Wayne D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2014Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic diseaseClarke, Christine; Doan, Tram Bich; Graham, Justine (Dinny); Hilton, Heidi; Kantimm, Silke; Kuczek, Elizabeth; Santucci, Nicole Louise; Silvestri, Audrey; Fuller., Peter J.; Funder, John W.; Huschtscha, Lily I; Leedman, Peter; Muscat, George E. O.; Oakes, Samantha; Ormandy, Christopher J.; Simpson, Evan R.; Tilley, Wayne D.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease, Oncotarget, vol.5, 18, 2014,pp 8651-8664
2014Breast cancer prognosis predicted by nuclear receptor-coregulator networksClarke, Christine; Doan, Tram Bich; Graham, Justine (Dinny); Kuczek, Elizabeth; Clyne, Colin; Eriksson, Natalie A; Fuller, Peter; Funder, John W.; Leedman, Peter J; Muscat, George E. O.; Simpson, Evan; Tilley, Wayne D.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Breast cancer prognosis predicted by nuclear receptor-coregulator networks, Molecular Oncology, vol.8, 5, 2014,pp 998-1013
2010Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcomeKench, James; Butler, Miriam S.; Callen, David Frederick; Holm, Ruth; Horsefall, David; Kumar, Raman; Neilsen, Paul M.; Nesland, Jahn M; Ricciardelli, Carmela; Schulz, Renee; Stahl, Jurgen; Stapleton, Alan; Tilley, Wayne D.; School of Medical Sciences: PathologyCo-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome, Oncology reports, vol.23, 4,pp 1045-1052
2010Comparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic ProstatectomiesKench, James; Bianco-Miotto, Tina; Clements, Judith A.; Cohen, Penelope A.; Dodd, Thomas J.; Dong, Ying; Horsfall, David J.; Jindal, Shalini; Marshall, Villis R; Ricciardelli, Carmela; Risbridger, Gail Petuna; Samaratunga, Hemamali; Sutherland, Peter D.; Sutherland, Robert L.; Tilley, Wayne D.; Wang, H; School of Medical Sciences: PathologyComparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic Prostatectomies, Cancer Epidemiology, Biomarkers & Prevention, vol.19, 7,pp 1755-1765
2008Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse.Horvath, Lisa; Butler, Miriam S.; Byers, Sharon; Henshall, Susan M.; Horsfall, David J.; Kench, James; Marshall, Villis R; Reinboth, Betty J.; Ricciardelli, Carmela; Sakko, Andrew J.; Stahl, Jurgen; Stricker, Phillip D.; Sutherland, Robert L.; Tilley, Wayne D.; Central Clinical School: MedicineImmunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse., Cancer Epidemiology, Biomarkers and Prevention, vol.17, 9, 2008,pp 2488-2497
2014PRMT2 and RORĪ³ expression are associated with breast cancer survival outcomesClarke, Christine; Bailey, Peter; Dray, Eloise; Eriksson, Natalie A; et al, Various; Fuller, Peter; Funder, John W.; Goode, Joel M; Oh, Taegyu; Simpson, Evan; Smith, Aaron; Tilley, Wayne D.; Western Clinical School: Westmead Millennium InstitutePRMT2 and RORĪ³ expression are associated with breast cancer survival outcomes, Molecular Endocrinology, vol.28, 7, 2014,pp 1166-1185